Peggy Scherle, Chief Scientific Officer at Prelude Therapeutics Inc (PRLD), sold 4,572 shares at $35.07 ($160K) on 2021-08-13, disclosed to the SEC on 2021-08-17.
Open-market sale of $160k PRLD by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.07 | 2,286 | $80K | 50.0% |
| 2 | $35.07 | 2,286 | $80K | 50.0% |
| Total | $35.07 avg | 4,572 | $160K | 100% |
| Filing → |
| PRLD | SELL | 2021-05-11 | $808K | — | Filing → |
| PRLD | SELL | 2021-04-15 | $296K | — | Filing → |
| PRLD | SELL | 2021-04-09 | $1.2M | — | Filing → |